✦ LIBER ✦

A High Occurrence of Acquisition and/or Expansion of C-CBL Mutant Clones in the Progression of High-Risk Myelodysplastic Syndrome to Acute Myeloid Leukemia

✍ Scribed by Kao, Hsiao-Wen; Sanada, Masashi; Liang, Der-Cherng; Lai, Chang-Liang; Lee, En-Hui; Kuo, Ming-Chung; Lin, Tung-Liang; Shih, Yu-Shu; Wu, Jin-Hou; Huang, Chein-Fuang; Ogawa, Seishi; Shih, Lee-Yung

Book ID: 122184713
Publisher: Neoplasia Press
Year: 2011
Tongue: English
Weight: 933 KB
Volume: 13
Category: Article
ISSN: 1522-8002
DOI: 10.1593/neo.111192

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of NEMO, the regulatory subun

Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia

✍ Carvalho, G; Fabre, C; Braun, T; Grosjean, J; Ades, L; Agou, F; Tasdemir, E; Boe 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 330 KB

177 Carboplatin(CBDCA) alone or in combi

177 Carboplatin(CBDCA) alone or in combination in the treatment of acute myeloid leukema (AML) secondary to myelodysplastic syndromes and in other high risk AML

✍ L. Larrea; M.A. Sanz; G. Martin; J.A. Martinez; I. Jarque; C. Jiménez; G.F. Sanz 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 118 KB

A comparison of low-dose cytarabine and

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment

✍ Alan K. Burnett; Donald Milligan; Archie G. Prentice; Anthony H. Goldstone; Mary 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Clofarabine in combination with a standa

Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)

✍ Willemze, R.; Suciu, S.; Muus, P.; Halkes, C. J. M.; Meloni, G.; Meert, L.; Karr 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 197 KB